Business · 23/10/2013Updated: 10/17/2026 · 1 min read
FDA Clears Potassium Citrate for Approval
Summary
The Food and Drug Administration (FDA) has determined that Potassium Citrate, 10 milliequivalents/packet and 20 milliequivalents/packet, was not withdrawn from sale for reasons of safety or effectiveness, paving the way for approval of abbreviated new drug applications (ANDAs) for these formulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →